Skip to main content

Dermagraft Helps Heal Diabetic Foot Ulcers

PD Fitness and WellBeing 67048 Dermagraft is a US Food and Drug Administration (FDA) approved skin substitute that helps heal diabetic foot ulcers. These ulcers are serious wounds that occur most often in the skin over the ball of the foot or on the bottom of the big toe.

Helping to Grow New Skin

Dermagraft is a dissolvable mesh material that contains human connective tissue cells called fibroblasts. Dermagraft is placed directly on the ulcer, where the mesh and fibroblasts are gradually absorbed. Fibroblasts produce many of the same factors found in healthy skin. As the fibroblasts attach and grow in the wound, they help replace and rebuild the damaged parts in the foot.

Dermagraft can be used on the following types of ulcers:

  • Full-thickness diabetic foot ulcers that have been present for longer than 6 weeks
  • Ulcers that extend deeper into the skin where the blood vessels are, but do not involve tendon, muscle, joint capsule, or bone

When Not to Use Dermagraft

There are certain cases when Dermagraft should not be used, such as:

The Importance of Careful Foot Care

People with diabetes are more likely to develop foot problems such as:

  • Changes in the skin of the feet, specifically drying and cracking
  • Nerve damage, which decreases feeling in the feet and allows wounds to occur unnoticed
  • Poor circulation, which makes fighting infection and wound healing difficult

These problems make people with diabetes more susceptible to sores. If you have diabetes, inspect your feet every day. Seek care right away if you have a foot injury. Also, have your feet checked by your doctor at least once a year.

  • American Diabetes Association

  • National Institute of Diabetes and Digestive and Kidney Diseases

  • Canadian Diabetes Association

  • Canadian Podiatric Medical Association

  • Dermagraft—P000036. US Food and Drug Administration website. Available at: Updated September 5, 2013. Accessed August 12, 2015.

  • Diabetic foot ulcer. EBSCO DynaMed website. Available at: Updated July 16, 2015. Accessed August 12, 2015.

  • Ehrenreich M, Ruszczak Z. Update on tissue-engineered biological dressings. Tissue Eng. 2006;12(9):2407-2424.

  • Marston WA. Dermagraft, a bioengineered human dermal equivalent for the treatment of chronic nonhealing diabetic foot ulcer. Expert Rev Med Devices. 2004;1(1):21-31.

  • Patient guide. Hannibal Regional Medical Group website. Available at: Accessed August 12, 2015.

The health information in this Health Library is provided by a third party. TriStar Health does not in any way create the content of this information. It is provided solely for informational purposes. It does not constitute medical advice and is not intended to be a substitute for proper medical care provided by a physician. Always consult with your doctor for appropriate examinations, treatment, testing, and care recommendations. Do not rely on information on this site as a tool for self-diagnosis. If you have a medical emergency, call 911.